Chargement en cours...

Cyclooxygenase 2-Regulated Genes an Alternative Avenue to the Development of New Therapeutic Drugs for Colorectal Cancer

Colorectal cancer (CRC) is one of the most common and recurrent types of cancer, with high mortality rates. Several clinical trials and meta-analyses have determined that the use of pharmacological inhibitors of cyclooxygenase 2 (COX-2), the enzyme that catalyses the rate-limiting step in the synthe...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Alicia M. Hidalgo-Estévez, Konstantinos Stamatakis, Marta Jiménez-Martínez, Ricardo López-Pérez, Manuel Fresno
Format: Artigo
Langue:Inglês
Publié: Frontiers Media S.A. 2020-04-01
Collection:Frontiers in Pharmacology
Sujets:
Accès en ligne:https://www.frontiersin.org/article/10.3389/fphar.2020.00533/full
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!